1. Haberland, C, Perou, M. Encephalocraniocutaneous lipomatosis. A new example of ectomesodermal dysgenesis. Arch Neurol. 1970; 22:144–55.
Google Scholar | Crossref | Medline2. Chacon-Camacho, OF, Lopez-Moreno, D, Morales-Sanchez, MA, et al. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies. Mol Genet Genomic Med. 2019; 7:e625.
Google Scholar | Crossref | Medline3. Happle, R, Küster, W. Nevus psiloliparus: a distinct fatty tissue nevus. Dermatol Basel Switz. 1998; 197:6–10.
Google Scholar | Crossref | Medline | ISI4. Moog, U. Encephalocraniocutaneous lipomatosis. J Med Genet. 2009; 46(11):721–729.
Google Scholar | Crossref | Medline5. Bennett, JT, Tan, TY, Alcantara, D, et al. Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis. Am J Hum Genet. 2016; 98:579–587.
Google Scholar | Crossref | Medline | ISI6. Venot, Q, Canaud, G. Segmental overgrowth syndromes and therapeutic strategies. Med Sci. 2020; 36:235–242.
Google Scholar7. Ruggieri, M, D, Pratico, A. Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol. 2015; 22:207–233.
Google Scholar | Crossref | Medline8. Boppudi, S, Bögershausen, N, Hove, HB, et al. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. Clin Genet. 2016; 90:334–342.
Google Scholar | Crossref | Medline9. Dorey, K, Amaya, E. FGF signalling: diverse roles during early vertebrate embryogenesis. Dev Camb Engl. 2010; 137:3731–3742.
Google Scholar | Crossref | Medline | ISI10. Ciruna, B, Rossant, J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell. 2001; 1:37–49.
Google Scholar | Crossref | Medline11. Hunter, AGW. Oculocerebrocutaneous and encephalocraniocutaneous lipomatosis syndromes: blind men and an elephant or separate syndromes? Am J Med Genet A. 2006; 140:709–726.
Google Scholar | Crossref | Medline | ISI12. Özdoğan, S, Saymaz, C, Yaltırık, CK, et al. Encephalocraniocutaneous lipomatosis: Haberland syndrome. Am J Case Rep. 2017; 18:1271–1275.
Google Scholar | Crossref | Medline13. Tekin, B, Yücelten, AD, Akpınar, IN, Ekinci, G. Coexistence of aplasia cutis and nevus psiloliparus – report of a novel case. Pediatr Dermatol. 2014; 31:746–748.
Google Scholar | Crossref | Medline14. Hamm, H. Cutaneous mosaicism of lethal mutations. Am J Med Genet. 1999; 85:342–345.
Google Scholar | Crossref | Medline15. MacLaren, MJ, Kluijt, I, Koole, FD. Ophthalmologic abnormalities in encephalocraniocutaneous lipomatosis. Doc Ophthalmol Adv Ophthalmol. 1995; 90:87–98.
Google Scholar | Crossref | Medline16. Alfonso, I, Lopez, PF, Cullen, RF, et al. Spinal cord involvement in encephalocraniocutaneous lipomatosis. Pediatr Neurol. 1986; 2:380–384.
Google Scholar | Crossref | Medline17. Moog, U, Jones, MC, Viskochil, DH, et al. Brain anomalies in encephalocraniocutaneous lipomatosis. Am J Med Genet A. 2007; 143A:2963–2972.
Google Scholar | Crossref | Medline | ISI18. Nowaczyk, MJ, Mernagh, JR, Bourgeois, JM, et al. Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis. Am J Med Genet. 2000; 91:261–266.
Google Scholar | Crossref | Medline | ISI19. Jenkins, D, McCuaig, C, A, Drolet, B, et al. Tuberous sclerosis complex associated with vascular anomalies or overgrowth. Pediatr Dermatol. 2016; 33:536–542.
Google Scholar | Crossref | Medline20. Walker, KA, Sims-Lucas, S, Bates, CM. Fibroblast growth factor receptor signaling in kidney and lower urinary tract development. Pediatr Nephrol. 2016; 31:885–895.
Google Scholar | Crossref | Medline21. Xie, Y, Su, N, Yang, J, et al. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther. 2020; 5:181.
Google Scholar | Crossref | Medline22. Koti, K, Bhimireddy, V, Dandamudi, S, Gunnamreddy, R. Encephalocraniocutaneous Lipomatosis (Haberl and syndrome): a case report and review of literature. Indian J Dermatol. 2013; 58:232–234.
Google Scholar | Crossref | Medline23. Thakur, S, Thakur, V, Sood, RG, et al. Encephalocraniocutaneous lipomatosis with calvarial exostosis – case report and review of literature. Indian J Radiol Imaging. 2013; 23:333–336.
Google Scholar | Crossref | Medline24. Habib, F, Elsaid, MF, Salem, KY, et al . Oculo-ectodermal syndrome: a case report and further delineation of the syndrome. Qatar Med J. 2014; 2014:114–122.
Google Scholar | Medline25. Brown, KE, Goldstein, SM, Douglas, RS, Katowitz, JA. Encephalocraniocutaneous lipomatosis: a neurocutaneous syndrome. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus. 2003; 7:148–149.
Google Scholar | Crossref26. Fishman, MA, Chang, CS, Miller, JE. Encephalocraniocutaneous lipomatosis. Pediatrics. 1978; 61:580–582.
Google Scholar | Medline | ISI27. Ferranti, S, Sardi, I, Guidi, M, et al. Case report: a case of glioblastoma in a patient with Haberland syndrome. Front Pediatr. 2021; 9:648717.
Google Scholar | Crossref | Medline28. Moog, U, Roelens, F, Mortier, GR, et al. Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: harboring clues to pathogenesis? Am J Med Genet A. 2007; 143:2973–2980.
Google Scholar | Crossref29. Gripp, KW, Baker, L, Kandula, V, et al. Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation. Am J Med Genet A. 2016; 170:2559–2569.
Google Scholar | Crossref | Medline30. Slack, JC, Bründler, MA, Chang, CA, et al. Bilateral nephroblastic tumors and a complex renal vascular anomaly in a patient with a mosaic RASopathy: novel histopathologic features and molecular insights. Pediatr Dev Pathol. 2021; 24:235–240.
Google Scholar | SAGE Journals | ISI31. Homsy, YL, Anderson, JH, Oudjhane, K, et al. Wilms tumor and multicystic dysplastic kidney disease. J Urol. 1997; 158:2256–2259.
Google Scholar | Crossref | Medline